Gapping up
In reaction to earnings/guidance:
- EGHT +13.2%, PINS +12.4%, TVTX +9.7%, DXCM +9.2%, CUBE +9.1%, CWST +6.7%, INTC +6.7%, TFII +5.6%, DRQ +5.5%, GILD +5.2%, VRTX +4.9%, EQNR +4.5%, PFSI +3.8%, KNSL +3.7%, PXD +3% (also declares quarterly base-plus-variable dividend of $5.71/sh), TMUS +3%, AB +3%, TEX +2.5%, BLMN +2.5%, SWN +2.3%, SNY +2.3%, XOM +2.2%, CVX +2.1%, FHI +2%, B +2%, CHD +1.9%, WETF +1.9%, CASH +1.6% (also names new CFO), RSG +1.4%, LTC +1.3%, SKYW +1.2%, NVT +1.2%, BAH +1.2%, CHTR +1.2%, NWL +1.1%
Other news:
- NUVL +11.1% (Preliminary Phase 1 Clinical Data from ARROS-1 Trial)
- CFFN +6.7% (to resume repurchasing shares)
- BFH +5.7% (moving to S&P Small Cap 600 from S&P MidCap 400)
- ACGL +5.6% (to join S&P 500)
- EPM +2.7% (names new CEO)
- ARIS +2.7% (acquires IP rights from Water Standard re reuse of produced water in Permian Basin)
- WTTR +2.5% (initiates regular dividend program)
- LQDA +1.9% (LQDA: patent panel denies UTHR request)
- BKR +1.7% (increases dividend and increases share repurchase auth by $2 bln to $4 bln)
Analyst comments:
- U +2.7% (upgraded to Overweight from Neutral at Piper Sandler)